Nilmary Grafals‐Ruiz

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Rac Inhibition As A Novel Therapeutic Strategy for EGFR/HER2 Targeted Therapy Resistant Breast Cancer”.

Rac Inhibition As A Novel Therapeutic Strategy for EGFR/HER2 Targeted Therapy Resistant Breast Cancer

Research Square(2020)10.21203/rs.3.rs-86620/v1

N/A

0DataRank · unranked

0 citations

María del Mar Maldonado, Julia Medina‐Velázquez, Angel Luis Troche‐Torres, Luis Velazquez‐Vega, Nilmary Grafals‐Ruiz +2 more

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

BMC Cancer(2021)10.1186/s12885-021-08366-7

N/A

0DataRank · unranked

20 citations

María del Mar Maldonado, Julia Medina‐Velázquez, Angel Luis Troche‐Torres, Luis Velázquez, Nilmary Grafals‐Ruiz +2 more

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

Translational Oncology(2024)10.1016/j.tranon.2024.101928

N/A

0DataRank · unranked

5 citations

Michael J. Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas‐Mejía, Miciely Aponte-Reyes, Ailed Cruz‐Collazo +6 more